Table 4 Laboratory test of 233 patients with COVID-19

Leucocyte (×10⁹/L, range 3.5–9.5)

233 (100%)

Increased

37 (15.9%)

20 (9.8%)

17 (60.7%)

Decreased

27 (11.6%)

25 (12.2%)

2 (7.1%)

Normal

169 (72.5%)

160 (78%)

9 (32.2%)

Neutrophil (×10⁹/ L, range 1.8–6.3)

233 (100%)

Increased

58 (24.9%)

36 (17.6%)

22 (78.6%)

Decreased

17 (7.3%)

16 (7.8%)

1 (3.6%)

Normal

130 (67.8%)

153 (74.6%)

5 (17.8%)

Lymphocyte (×10⁹/ L, range 1.1–3.2)

233 (100%)

Decreased

132 (57.6%)

110 (53.7%)

22 (78.6%)

Normal

101 (42.2%)

95 (46.3%)

6 (21.4%)

Platelet (×10⁹/ L, range 125–450)

233 (100%)

Increased

7 (3.1%)

6 (2.9%)

1 (3.6%)

Decreased

29 (12.4%)

23 (11.2%)

6 (21.4%)

Normal

197 (84.5%)

176 (85.9%)

21 (75%)

D-Dimer (mg/L; range < 0.55)

34 (15%)

Increased

19 (55.9%)

12 (35.3%)

7 (20.6%)

Normal

15 (44.1%)

15 (64.7%)

0

ALT (IU/L, range 0–64)

202 (87%)

Increased

22 (10.9%)

19 (10.6%)

3 (13.1%)

Normal

180 (89.1%)

160 (89.4%)

20 (86.9%)

AST (IU/L, range 8–40)

202 (87%)

Increased

74 (36.6%)

57 (31.8%)

17 (73.9%)

Normal

128 (63.4%)

122 (68.2%)

6 (26.1%)

ALK.P (IU/L, range 25–320)

195 (84%)

Increased

36 (18.5%)

30 (17.2%)

6 (28.6%)

Normal

159 (81.5%)

144 (82.8%)

15 (71.4%)

Total Bilirubin (mg/dL, range 0.4–1.3)

180 (77%)

Increased

24 (13.3%)

19 (11.8%)

5 (26.3%)

Decreased

8 (4.4%)

8 (5.1%)

0

Normal

148 (82.3%)

134 (83.1%)

14 (73.7%)

Direct Bilirubin (mg/dL, range 0.1–0.3)

180 (77%)

Increased

73 (40.6%)

62 (38.5%)

11 (57.9%)

Decreased

36 (20%)

33 (20.5%)

3 (15.7%)

Normal

71 (39.4%)

66 (41%)

5 (26.4%)

Bun (mg/dL, range 5–24)

225 (97%)

Increased

59 (26.2%)

38 (19.1%)

21 (80.8%)

Normal

166 (73.8%)

161 (80.9%)

5 (19.2%)

Creatinine (mg/dL, range 0.5–1.4)

223 (96%)

Increased

58 (26%)

40 (20.3%)

18 (69.2%)

Normal

165 (74%)

157 (79.7%)

8 (30.8%)

CPK (IU/L, range 12–160)

183 (79%)

Increased

68 (37.2%)

57 (35%)

11 (55%)

Normal

115 (62.8%)

106 (65%)

9 (45%)

LDH (IU/L, range 140–280)

173 (74%)

Increased

168 (97.1%)

151 (97.4%)

17 (94%)

Normal

5 (2.9%)

4 (2.6%)

1 (6%)

C-Reactive Protein (mg/L, 0.0–6.0)

233 (100%)

Increased

206 (88.4%)

179 (87.3%)

27 (96.4%)

Normal

27 (11.6%)

26 (12.7%)

1 (3.6%)

ESR (mm/h, 2–22)

162 (70%)

Increased

139 (85.8%)

124 (90.7%)

15 (100%)

Normal

23 (14.2%)

23 (9.3%)

0

NA (mEq/L, 135–145)

209 (90%)

Increased

7 (3.4%)

3 (1.6%)

4 (16%)

Decreased

96 (45.9%)

85 (46.2%)

11 (44%)

Normal

106 (50.7%)

96 (52.2%)

10 (40%)

K (mEq/L, 3.5–5.5)

208 (90%)

Increased

3 (1.4%)

0

3 (12%)

Decreased

49 (23.6%)

43 (23.5%)

6 (24%)

Normal

156 (75%)

140 (76.5%)

16 (64%)

NLR (index, < 5)

233 (100%)

Increased

95 (40.8%)

69 (33.7%)

26 (92.9%)

Normal

138 (59.2%)

136 (66.3%)

2 (7.1%)

PLR (index, < 200)

233 (100%)

Increased

104 (44.6%)

84 (40.9%)

20 (71.4%)

Normal

129 (55.4%)

121 (59.1%)

8 (28.6%)

SII (index, < 500)

233 (100%)

Increased

159 (68.2%)

133 (64.9%)

26 (92.9%)

Normal

74 (31.8%)

72 (35.1%)

2 (7.1%)